Mechanisms governing the protective effect of 17β-estradiol and estrogen receptors against cardiomyocyte injury

BioMedicine (Netherlands)

Volumn 1, Issue 1, 2011, Pages 21-28

  Lin, Ding Yu ^a   Tsai, Fuu Jen ^a   Tsai, Chang Hai ^b   Huang, Chih Yang ^a,b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b ASIA UNIVERSITY   (Taiwan)

Author keywords

17 estradiol; Cardioprotective signaling pathways; Estrogen receptors

Indexed keywords

CALCINEURIN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR 30; LIPOPOLYSACCHARIDE; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN B;

CARDIOMYOPATHY; CELL DAMAGE; CELL PROTECTION; HEART INJURY; HEART MUSCLE CELL; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION;

EID: 84861187789     PISSN: 22118020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomed.2011.10.004     Document Type: Review

References (46)

1. Jousilahti P., Vartianen E., Tuomilehto J., Puska P. Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in finland. Circulation 1999, 99:1165-1172.
2. Patten R.D., Karas R.H. Estrogen replacement and cardiomyocyte protection. Trends Cardiovasc Med 2006, 16:69-75.
3. Rosano G.M., Vitale C., Silvestri A., Fini M. Hormone replacement therapy and cardioprotection: the end of the tale?. Ann N Y Acad Sci 2003, 997:351-357.
4. Kim J.K., Levin E.R. Estrogen signaling in the cardiovascular system. Nucl Recept Signal 2006, 4:e013. Epub 2006 Jul 7.
5. Patten R.D., Pourati I., Aronovitz M.J., Baur J., Celestin F., Chen X., et al. 17beta-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling. Circ Res 2004, 95:692-699.
6. Lannigan D.A. Estrogen receptor phosphorylation. Steroid 2003, 68:1-9.
7. Prossnitz E.R., Barton M. Signaling, physiological functions and clinical relevance of the G protein-coupled estrogen receptor GPER. Prostaglandins Other Lipid Mediat 2009, 89(3-4):89-97.
8. Gustafsson J.A. Estrogen receptor β - a new dimension in estrogen mechanism of action. J Endocrinol 1999, 163:379-383.
9. Moras D., Gronemeyer H. The nuclear receptor ligand-binding domain: structure and function. Curr Opin Cell Biol 1998, 10:384-391.
10. Heldring N., Pike A., Andersson S., Matthews J., Cheng G., Hartman J., et al. Estrogen receptors: how do they signal and what are their targets. Physiol Rev 2007, 87:905-931.
11. Shou J., Massarweh S., Osborne C.K., Wakeling A.E., Ali S., Weiss H., et al. Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer. J Natl Cancer Inst 2004, 96:926-935.
12. Schwabe J.W., Neuhaus D., Rhodes D. Solution structure of the DNA-binding domain of the oestrogen receptor. Nature 1990, 348:458-461.
13. Zhao C., Dahlman-Wright K., Gustafsson J.A. Estrogen receptor beta: an overview and update. Nucl Recept Signal 2008, 6:e003.
14. Prossnitz E.R., Arterburn J.B., Smith H.O., Oprea T.I., Sklar L.A., Hathaway H.J. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu Rev Physiol 2008, 70:165-190.
15. Raetz C.R., Whitfield C. Lipopolysaccharide endotoxins. Annu Rev Biochem 2002, 71:635-700.
16. Tavener S.A., Kubes P. Is there a role for cardiomyocyte toll-like receptor 4 in endotoxemia?. Trends Cardiovasc Med 2005, 15:153-157.
17. Liu C.J., Lo J.F., Kuo C.H., Chu C.H., Chen L.M., Tsai F.J., et al. Akt mediates 17beta-estradiol and/or estrogen receptor-alpha inhibition of LPS-induced tumor necrosis factor-alpha expression and myocardial cell apoptosis by suppressing the JNK1/2-NFkappaB pathway. J Cell Mol Med 2009, 13(9B):3655-3667.
18. Pelzer T., Neumann M., de Jager T., Jazbutyte V., Neyses L. Estrogen effects in the myocardium: inhibition of NF-kappaB DNA binding by estrogen receptor-alpha and -beta. Biochem Biophys Res Commun 2001, 286:1153-1157.
19. Heineke J., Molkentin J.D. Regulation of cardiac hypertrophy by intracellular signaling pathways. Nat Rev Mol Cell Biol 2006, 7:589-600.
20. Crowley S.D., Gurley S.B., Herrera M.J., Ruiz P., Griffith R., Kumar A.P., et al. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci USA 2006, 103:17985-17990.
21. Barry S.P., Davidson S.M., Townsend P.A. Molecular regulation of cardiac hypertrophy. Int J Biochem Cell Biol 2008, 40:2023-2039.
22. Freund C., Schmidt-Ullrich R., Baurand A., Dunger S., Schneider W., Loser P., et al. Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo. Circulation 2005, 111:2319-2325.
23. Fiedler B., Lohmann S.M., Smolenski A., Linnemuller S., Pieske B., Schroder F., et al. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes. Proc Natl Acad Sci U S A 2002, 99:11363-11368.
24. Donaldson C., Eder S., Barker C., Aronovitz M.J., Weiss A.D., Hall-Porter M., et al. Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation. Circ Res 2009, 104:265-275.
25. Lin D.Y., Liu C.N., Liu C.J., Tsai F.J., Tsai C.H., Kuo W.W., et al. PI3 K signaling mediates 17β-estradiol and/or estrogen receptor β inhibition of isoproterenol-induced cardiac hypertrophy and calcineurin-PP1 signaling activation in H9c2 cardiomyoblast cells 2009 Aug 2-5, IX World Congress of the International Society for Adaptive Medicine, Taipei, Taiwan.
26. Liu C.J., Kuo C.H., Chen L.M., Tsai F.J., Kuo W.W., Huang C.Y. Akt mediates 17β-estradiol and/or estrogen receptor α inhibition of LPS-induced tumor necrosis factor-α expression and myocardial cell apoptosis by suppressing the JNK1/2-NFκB Pathway 2009 Dec 12-7, Annual International Congress of Cardiology, Shanghai Everbright Convention & Exhibition Center, Shanghai, China.
27. Filardo E.J., Quinn J.A., Bland K.I., Frackelton A.R. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 2000, 14:1649-1660.
28. Yen C.Y., Kuo W.W., Tsai F.J., Huang C.Y. 17β-estradiol and/or estrogen receptor α against protein Phosphatase 2A (PP2A)-induced cardiomyocyte hypertrophy through inhibiting calcium accumulation 2009 Oct 23-25, 23th Joint Annual Conference of Biomedical Science, National Defense Medical Center, Taipei, Taiwan.
29. Evidence and research cluster. The global burden of disease 2004 update 2004, World Health Organization Department of Health Statistics and Informatics in the Information, World Health Organization, Geneva.
30. Saraste A., Pulkki K., Kallajoki M., Henriksen K., Parvinen M., Voipio-Pulkki L.M. Apoptosis in human acute myocardial infarction. Circulation 1997, 95:320-323.
31. Yang S., Zheng R., Hu S., Ma Y., Choudhry M.A., Messina J.L., et al. Mechanism of cardiac depression after trauma-hemorrhage: increased cardiomyocyte IL-6 and effect of sex steroids on IL-6 regulation and cardiac function. Am J Physiol Heart Circ Physiol 2004, 287:H2183-H2191.
32. Hayward C.S., Kelly R.P., Collins P. The roles of gender, the menopause and hormone replacement on cardiovascular function. Cardiovasc Res 2000, 46:28-49.
33. Xu Y., Arenas I.A., Armstrong S.J., Plahta W.C., Xu H., Davidge S.T. Estrogen improves cardiac recovery after ischemia/reperfusion by decreasing tumor necrosis factor-alpha. Cardiovasc Res 2006, 69:836-844.
34. Vanden Hoek T.L., Li C., Shao Z., Schumacker P.T., Becker L.B. Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion. J Mol Cell Cardiol 1997, 29:2571-2583.
35. Robin E., Guzy R.D., Loor G., Iwase H., Waypa G.B., Marks J.D., et al. Oxidant stress during simulated ischemia primes cardiomyocytes for cell death during reperfusion. J Biol Chem 2007, 282:19133-19143.
36. Liu H., Pedram A., Kim J.K. Oestrogen prevents cardiomyocyte apoptosis by suppressing p38α-mediated activation of p53 and by down-regulating p53 inhibition on p38β. Cardiovasc Res 2011, 89:119-128.
37. Lin J., Steenbergen C., Murphy E., Sun J. Estrogen receptor-beta activation results in S-nitrosylation of proteins involved in cardioprotection. Circulation 2009, 120:245-254.
38. Urata Y., Ihara Y., Murata H., Goto S., Koji T., Yodoi J., et al. 17Beta-estradiol protects against oxidative stress-induced cell death through the glutathione/glutaredoxin-dependent redox regulation of Akt in myocardiac H9c2 cells. J Biol Chem 2006, 281:13092-13102.
39. Weng Y.J., Kuo W.W., Kuo C.H., Tung K.C., Tsai C.H., Lin J.A., et al. BNIP3 induces IL6 and calcineurin/NFAT3 hypertrophic-related pathways in H9c2 cardiomyoblast cells. Mol Cell Biochem 2010, 345(1-2):241-247.
40. Weng Y.J., Kuo W.W., Tsai C.H., Lin T.E., Huang C.Y. Regulatory mechanism of 17β-estradiol and/or estrogen receptor β on hypoxia-induced BNIP3 autophagic and apoptotic pathways in H9c2 cardiomyoblast cells. First symposium on adaptive medicine and adaptability across the strait 2010 Sep 10-12, National Yang-Ming University, Taipei, Taiwan.
41. Weil B.R., Manukyan M.C., Herrmann J.L., Wang Y., Abarbanell A.M., Poynter J.A., et al. Signaling via GPR30 protects the myocardium from ischemia/reperfusion injury. Surgery 2010, 148:436-443.
42. Ghosh P., Dahms N.M., Kornfeld S. Mannose 6-phosphate receptors: new twists in the tale. Nat Rev Mol Cell Biol 2003, 4:202-212.
43. Chang M.H., Kuo W.W., Chen R.J., Lu M.C., Tsai F.J., Kuo W.H., et al. IGF-II/mannose 6-phosphate receptor activation induces metalloproteinase-9 matrix activity and increases plasminogen activator expression in H9c2 cardiomyoblast cells. J Mol Endocrinol 2008, 41:65-74.
44. Chu C.H., Tzang B.S., Chen L.M., Kuo C.H., Cheng Y.C., Chen Y.L., et al. IGF-II/mannose-6-phosphate receptor signaling induced cell hypertrophy and atrial natriuretic peptide/BNP expression via Galphaq interaction and protein kinase C-alpha/CaMKII activation in H9c2 cardiomyoblast cells. J Endocrinol 2008, 197:381-390.
45. Chen R.J., Wu H.C., Chang M.H., Lai C.H., Tien Y.C., Hwang J.M., et al. Leu27IGF2 plays an opposite role to IGF1 to induce H9c2 cardiomyoblast cell apoptosis via Galphaq signaling. J Mol Endocrinol 2009, 43:221-230.
46. Weng Y.S., Huang C.Y. Inhibition of 17β-estradiol on IGF2R induced cardiac hypertrophy and apoptotic effects 2010 Mar 27-28, 25th Joint Annual Conference of Biomedical Science, National Defense Medical Center, Taipei, Taiwan.